author-photo

Kun-Ming Rau

Chang Gung University

53

Papers

639

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2.

2021 Cell & Bioscience
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of the Pan-Asian Subgroup of patients in the NALA Trial: A Randomized Phase III NALA Trial Comparing Neratinib + Capecitabine (N+C) vs Lapatinib + Capecitabine (L+C) in Patients with HER2+ Metastatic Breast Cancer (mBC) Previously Treated with Two or more HER2-Directed Regimens

2021
Show All
- Source
- Cite
- Save
Citations (0)
Divergent Roles of Induction Chemotherapy in Patients with Unresectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Population-Based Matched Cohort Study

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.

2021 British Journal of Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis

2020 International Journal of Nanomedicine
Show All
- Source
- Cite
- Save
Citations (8)
Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (5)
S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Induction bevacizumab, etoposide and cisplatin followed by whole brain radiotherapy (WBRT) versus WBRT alone in breast cancer with untreated brain metastases: Results of a randomized phase II A-PLUS trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline α-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Taiwan nutritional consensus on the nutrition management for gastric cancer patients receiving gastrectomy.

2019 Journal of the Formosan Medical Association
Show All
- Source
- Cite
- Save
Citations (4)